Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Two Levothyroxine Formulations in Healthy Volunteers
NCT01536678Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by GSK. Primary endpoints: Maximum Observed Concentration and Area Under the Concentration-Time Curve. Started Jan 2012; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT01536678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536678.